Kits for the treatment or prophylaxis of depressed mood are described, for subjects with increased MAO-A levels, excessive crying, or subjects within or beyond the 5-day postpartum period. The kits are used to implement a method by which the subject is administered an antioxidant source on at least the first day of a 3 to 5 day regime; a tryptophan composition on the evening of the penultimate treatment day, simultaneously or following the antioxidant source; and a tyrosine composition the day after the tryptophan composition, on the final treatment day. The kit comprises an antioxidant source which may comprise or be derived from blueberries. Individuals with depressed mood due to perimenopause, alcohol use disorders or withdrawal, or who are up to or beyond 18-months postpartum, may benefit from the kits. The kits described may reduce the likelihood of advancing from depressed mood to depression.

Kits for the treatment or prophylaxis of depressed mood are described, for subjects with increased MAO-A levels, excessive crying, or subjects within or beyond the 5-day postpartum period. The kits are used to implement a method by which the subject is administered an antioxidant source on at least the first day of a 3 to 5 day regime; a tryptophan composition on the evening of the penultimate treatment day, simultaneously or following the antioxidant source; and a tyrosine composition the day after the tryptophan composition, on the final treatment day. The kit comprises an antioxidant source which may comprise or be derived from blueberries. Individuals with depressed mood due to perimenopause, alcohol use disorders or withdrawal, or who are up to or beyond 18-months postpartum, may benefit from the kits. The kits described may reduce the likelihood of advancing from depressed mood to depression.

A semi-solid chewable composition, comprising an herbal composition and a semi-chewable base. The herbal composition comprises anti-inflammatory, anti-microbial, analgesic, antiseptic, or antipyrelic herbal composition.

A semi-solid chewable composition, comprising an herbal composition and a semi-chewable base. The herbal composition comprises anti-inflammatory, anti-microbial, analgesic, antiseptic, or antipyrelic herbal composition.

A semi-solid chewable composition, comprising an herbal composition and a semi-chewable base. The herbal composition comprises anti-inflammatory, anti-microbial, analgesic, antiseptic, or antipyrelic herbal composition.

A microbial Chinese herbal medicine feed having effects of detoxication, muttony odor removal, flavor enhancement and mutton quality improvement, comprising 190-1920 parts of feed substrate, 39-238 parts of additives, 1-65 parts of Chinese herbal medicine components, and 100-550 parts of forage powder; the Chinese herbal medicine components comprise fructus aurantii, dried tangerine peel, Amomum villosum and so on. The formula of the invention can obviously decrease the synthesis of short-chain fatty acids and C18 fatty acids in sheep, inhibit and block the further combination of C6, C8 and C10 into stable complexes or associations to the greatest extent and effectively improve the quality of the mutton, particularly effective in removing odor of the mutton.

A microbial Chinese herbal medicine feed having effects of detoxication, muttony odor removal, flavor enhancement and mutton quality improvement, comprising 190-1920 parts of feed substrate, 39-238 parts of additives, 1-65 parts of Chinese herbal medicine components, and 100-550 parts of forage powder; the Chinese herbal medicine components comprise fructus aurantii, dried tangerine peel, Amomum villosum and so on. The formula of the invention can obviously decrease the synthesis of short-chain fatty acids and C18 fatty acids in sheep, inhibit and block the further combination of C6, C8 and C10 into stable complexes or associations to the greatest extent and effectively improve the quality of the mutton, particularly effective in removing odor of the mutton.

A method for the treatment or prophylaxis of depressed mood is described, for subjects with increased MAO-A levels, subjects prone to excessive crying, or beyond 5-days postpartum. The subject is administered an antioxidant source on at least the first day of a 3 to 5 day regime; a tryptophan composition on the evening of the penultimate treatment day, simultaneously or following the antioxidant source; and a tyrosine composition the day after the tryptophan composition, on the final treatment day. The antioxidant source may comprise blueberries or another anthocyanin-containing fruit, vegetable, nut, legume, or a juice or extract thereof. Individuals with depressed mood due to perimenopause, due to an alcohol use disorder or withdrawal therefrom, or who are in a postpartum period up to or beyond 18-months, may benefit from the treatment regime. The described method can reduce the likelihood of advancing from depressed mood to postpartum depression in the postpartum period.

A method for the treatment or prophylaxis of depressed mood is described, for subjects with increased MAO-A levels, subjects prone to excessive crying, or beyond 5-days postpartum. The subject is administered an antioxidant source on at least the first day of a 3 to 5 day regime; a tryptophan composition on the evening of the penultimate treatment day, simultaneously or following the antioxidant source; and a tyrosine composition the day after the tryptophan composition, on the final treatment day. The antioxidant source may comprise blueberries or another anthocyanin-containing fruit, vegetable, nut, legume, or a juice or extract thereof. Individuals with depressed mood due to perimenopause, due to an alcohol use disorder or withdrawal therefrom, or who are in a postpartum period up to or beyond 18-months, may benefit from the treatment regime. The described method can reduce the likelihood of advancing from depressed mood to postpartum depression in the postpartum period.

A method for the treatment or prophylaxis of depressed mood is described, for subjects with increased MAO-A levels, subjects prone to excessive crying, or beyond 5-days postpartum. The subject is administered an antioxidant source on at least the first day of a 3 to 5 day regime; a tryptophan composition on the evening of the penultimate treatment day, simultaneously or following the antioxidant source; and a tyrosine composition the day after the tryptophan composition, on the final treatment day. The antioxidant source may comprise blueberries or another anthocyanin-containing fruit, vegetable, nut, legume, or a juice or extract thereof. Individuals with depressed mood due to perimenopause, due to an alcohol use disorder or withdrawal therefrom, or who are in a postpartum period up to or beyond 18-months, may benefit from the treatment regime. The described method can reduce the likelihood of advancing from depressed mood to postpartum depression in the postpartum period.